On Sinopharm

We welcome the Emergency Use Listing (EUL) of the World Health Organization for Sinopharm.

This development would strengthen our diversified vaccine portfolio as we continue to work on improving access to safe and effective vaccines, including Sinopharm.

To date, we have received more than 7.5-M anti-COVID 19 vaccines, and with the arrival of the bulk of our vaccine orders in the coming months, we are confident that we would be able to speed up our coronavirus vaccination program.